APOE and Dravet syndrome: The latest research analyzing the association of the APOE genotype with AD biomarkers in patients with DS showed that APOE ε4 allele carriers showed earlier increases in plasma p-tau181, starting from the mid-40s and with confidence intervals not overlapping by age 50 years [45].